Player FM - Internet Radio Done Right
Checked 2d ago
Lagt till two år sedan
תוכן מסופק על ידי touchpodcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי touchpodcast או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
Player FM - אפליקציית פודקאסט
התחל במצב לא מקוון עם האפליקציה Player FM !
התחל במצב לא מקוון עם האפליקציה Player FM !
פודקאסטים ששווה להאזין
בחסות
T
The Unshakeables
![The Unshakeables podcast artwork](https://cdn.player.fm/images/12013644/series/aHPUZCOIBTqDJuWB/32.jpg 32w, https://cdn.player.fm/images/12013644/series/aHPUZCOIBTqDJuWB/64.jpg 64w, https://cdn.player.fm/images/12013644/series/aHPUZCOIBTqDJuWB/128.jpg 128w, https://cdn.player.fm/images/12013644/series/aHPUZCOIBTqDJuWB/256.jpg 256w, https://cdn.player.fm/images/12013644/series/aHPUZCOIBTqDJuWB/512.jpg 512w)
![The Unshakeables podcast artwork](/static/images/64pixel.png)
1 On the Right Foot: Esquivel Designs 34:52
34:52
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:52![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
George Esquivel started making shoes for himself and some friends, up-and-coming musicians in Southern California. Soon, Hollywood came calling. And it wasn’t just celebrities who took notice. A film financier did, too. He said he wanted to invest in the company, but George soon realized his intentions weren’t what they seemed. Join Ben and special guest host Kathleen Griffith as they speak to George about the rise of Esquivel Designs. Hear what a meeting with Anna Wintour is really like, and what happens when you’re betrayed by someone inside your company. These are The Unshakeables. See omnystudio.com/listener for privacy information.…
touchPODCAST
סמן הכל כלא נצפה...
Manage series 3389426
תוכן מסופק על ידי touchpodcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי touchpodcast או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
102 פרקים
סמן הכל כלא נצפה...
Manage series 3389426
תוכן מסופק על ידי touchpodcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי touchpodcast או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
102 פרקים
Alla avsnitt
×![Artwork](/static/images/128pixel.png)
1 Updates in BCMA-directed therapies in multiple myeloma from ASH 2024 55:57
55:57
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי55:57![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for ONCOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice. The experts Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic This touchPODCAST is for HCPs outside of the USA and UK. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/…
![Artwork](/static/images/128pixel.png)
1 Updates in BCMA-directed therapies in multiple myeloma from ASH 2024 55:57
55:57
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי55:57![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchHAEMATOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice. The experts Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic This touchPODCAST is for HCPs outside of the USA and UK. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/…
![Artwork](/static/images/128pixel.png)
1 RAS mutations and personalized cancer care: Targeting the future 31:02
31:02
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי31:02![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchONCOLOGY Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes. The experts Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Dr Eileen M O’Reilly, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA Dr Rebecca S Heist, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Revolution Medicines . This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/mutations-and-personalized-cancer-care-targeting-the-future/…
![Artwork](/static/images/128pixel.png)
1 What’s new in primary ITP? Key updates from ASH 2024 40:35
40:35
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:35![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchONCOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition. The experts Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#…
![Artwork](/static/images/128pixel.png)
1 What’s new in primary ITP? Key updates from ASH 2024 40:35
40:35
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:35![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition. The experts Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#…
![Artwork](/static/images/128pixel.png)
1 Focused insights: Data implications of ADCs in NSCLC treatment 21:54
21:54
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי21:54![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future. The expert Prof. Céline Mascaux, Strasbourg University, Strasbourg, France This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchrespiratory.org/ADCs-in-NSCLC…
![Artwork](/static/images/128pixel.png)
1 Focused insights: Data implications of ADCs in NSCLC treatment 21:54
21:54
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי21:54![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchONCOLOGY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future. The expert Prof. Céline Mascaux, Strasbourg University, Strasbourg, France This touchPODCAST is for HCPs only This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchoncology.org/ADCs-in-NSCLC…
![Artwork](/static/images/128pixel.png)
1 Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY 1:20:58
1:20:58
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי1:20:58![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies. Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic This touchPODCAST is for HCPs in the USA. This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncologyime.org…
![Artwork](/static/images/128pixel.png)
1 Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY 1:20:58
1:20:58
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי1:20:58![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies. Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic This touchPODCAST is for HCPs in the USA. This activity is funded by an independent medical education grant from Sanofi. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchhaematologyime.org…
![Artwork](/static/images/128pixel.png)
1 Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY 37:37
37:37
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי37:37![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The experts Dr AeRang Kim, Children's National Hospital, Washington, DC, USA Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Springworks Therapeutics, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/expert-focus-management-of-nf1/…
![Artwork](/static/images/128pixel.png)
1 Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY 37:38
37:38
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי37:38![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The experts Dr AeRang Kim, Children's National Hospital, Washington, DC, USA Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Springworks Therapeutics, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/expert-focus-management-of-nf1/…
![Artwork](/static/images/128pixel.png)
1 Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting 38:15
38:15
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי38:15![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality. The experts Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands Prof. Thomas Powles, Barts Cancer Centre, London, UK Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY 34:20
34:20
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:20![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland Dr Teresa Amaral, Tübingen University, Tübingen, Germany This touchPODCAST is for healthcare professionals outside of the UK only This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma…
![Artwork](/static/images/128pixel.png)
1 Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY 34:19
34:19
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:19![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland Dr Teresa Amaral, Tübingen University, Tübingen, Germany This touchPODCAST is for healthcare professionals outside of the UK only This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma…
![Artwork](/static/images/128pixel.png)
1 Advances in IOL technology and power calculations: Updates and innovations from 2024 13:58
13:58
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:58![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology. The expert Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchophthalmology.com/…
![Artwork](/static/images/128pixel.png)
1 Supporting healing in epidermolysis bullosa: Innovations and new directions for care 18:55
18:55
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי18:55![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchDERMATOLOGY Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach . The expert: Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Chiesi USA Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchDERMA.com…
![Artwork](/static/images/128pixel.png)
1 Primary biliary cholangitis: Appraising the changing therapeutic landscape 35:31
35:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי35:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME . For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape…
![Artwork](/static/images/128pixel.png)
1 Primary biliary cholangitis: Appraising the changing therapeutic landscape 35:31
35:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי35:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/p rimary-biliary-cholangitis-therapeutic-landscape…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 13:46
13:46
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:46![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchONCOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 16:05
16:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי16:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchONCOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4 13:46
13:46
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:46![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchRESPIRATORY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3 16:05
16:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי16:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchRESPIRATORY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? 15:14
15:14
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:14![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidance on monitoring for and management of possible immune-related side effects. The multidisciplinary team Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands Pulmonologist – Dr Lizza Hendriks, Maastricht University Medical Center, Maastricht, The Netherlands Medical oncologist – Dr Jacob Sands Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? 13:57
13:57
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:57![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights. The multidisciplinary team Medical oncologist – Dr Jacob Sands Dana-Farber Cancer Institute, Boston, MA, USA Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchRESPIRATORY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? 14:53
14:53
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:53![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review the novel and emerging late-phase ICIs for LS-SCLC. The multidisciplinary team: Pulmonologist – Dr Lizza Hendriks, Maastricht University Medical Center, Maastricht, The Netherlands Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchONCOLOGY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? 15:14
15:14
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:14![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidance on monitoring for and management of possible immune-related side effects. The multidisciplinary team Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands Pulmonologist – Dr Lizza Hendriks, Maastricht University Medical Center, Maastricht, The Netherlands Medical oncologist – Dr Jacob Sands Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchONCOLOGY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? 13:57
13:57
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:57![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights. The multidisciplinary team Medical oncologist – Dr Jacob Sands Dana-Farber Cancer Institute, Boston, MA, USA Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 touchMDT for touchONCOLOGY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? 14:53
14:53
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:53![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review the novel and emerging late-phase ICIs for LS-SCLC. The multidisciplinary team: Pulmonologist – Dr Lizza Hendriks, Maastricht University Medical Center, Maastricht, The Netherlands Radiation oncologist – Prof. Suresh Senan Amsterdam University Medical Center, Amsterdam, The Netherlands This touchPODCAST is for HCPs outside the UK. This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/where-to-next-in-limited-stage-small-cell-lung-cancer-the-role-of-immune-checkpoint-inhibitors/…
![Artwork](/static/images/128pixel.png)
1 Vaccination strategies for pneumococcal disease 33:06
33:06
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי33:06![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES In this activity, Prof. Antoni Torres, a leading expert in respiratory infections, discusses the burden of pneumococcal disease in vulnerable patient populations, the evolving landscape of Streptococcus pneumoniae subtypes and the role that next-generation vaccines can play in preventing severe pneumococcal infections. The expert Prof. Antoni Torres, University of Barcelona, Spain This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck Sharp & Dohme LLC . This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchINFECTIOUS DISEASES.com…
![Artwork](/static/images/128pixel.png)
1 Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024 52:36
52:36
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי52:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchONCOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical practice. Overview Data reviews with Prof. Rosti Expert panel discussions with Prof. Susanne Saussele and Dr Carla Boquimpani on the themes below Clinical themes Approved and emerging TKIs for CML in the first-line setting Approved and emerging TKIs for CML in the second- and later-line settings Potential impact of emerging data on current and future clinical practice The internationally renowned multiple myeloma expert faculty Prof. Gianantonio Rosti: Meldola, Italy Prof. Susanne Saussele: Mannheim, Germany Dr Carla Boquimpani: Rio de Janeiro, Brazil This touchPODCAST is for HCPs globally with the exclusion of the USA, the UK and Japan . This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME. For further information visit our website: TBC…
![Artwork](/static/images/128pixel.png)
1 Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024 52:36
52:36
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי52:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchHAEMATOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical practice. Overview Data reviews with Prof. Rosti Expert panel discussions with Prof. Susanne Saussele and Dr Carla Boquimpani on the themes below Clinical themes Approved and emerging TKIs for CML in the first-line setting Approved and emerging TKIs for CML in the second- and later-line settings Potential impact of emerging data on current and future clinical practice The internationally renowned multiple myeloma expert faculty Prof. Gianantonio Rosti: Meldola, Italy Prof. Susanne Saussele: Mannheim, Germany Dr Carla Boquimpani: Rio de Janeiro, Brazil This touchPODCAST is for HCPs globally with the exclusion of the USA, the UK and Japan . This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME. For further information visit our website: TBC…
![Artwork](/static/images/128pixel.png)
1 Pharmacological management of agitation in Alzheimer's dementia 34:28
34:28
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:28![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology. The experts Prof. Jeffrey Cummings, University of Nevada, Las Vegas, NV, USA Prof. Krista Lanctôt, University of Toronto, ON, Canada Prof. James Galvin, University of Miami, FL, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA). For further information visit: https://touchneurologyime.org/cme/curriculums/agitation-in-alzheimers-dementia/…
![Artwork](/static/images/128pixel.png)
1 touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchRESPIRATORY 35:33
35:33
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי35:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchRESPIRATORY Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. The experts Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium For further information visit our website: www.touchRESPIRATORY.com…
![Artwork](/static/images/128pixel.png)
1 touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchCARDIO 35:33
35:33
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי35:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchCARDIO Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hypertension, patient risk stratification to support treatment decision-making and considerations for optimizing patient care in an evolving treatment landscape. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. The experts Prof. Manreet Kanwar, Allegheny General Hospital, Pittsburgh, PA, USA Prof. Jean-Luc Vachiéry, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium For further information visit our website: www.touchCARDIO.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1 14:12
14:12
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:12![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchONCOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2 15:59
15:59
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:59![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchONCOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1 14:12
14:12
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:12![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchRESPIRATORY.com…
![Artwork](/static/images/128pixel.png)
1 touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2 15:59
15:59
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:59![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchRESPIRATORY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchRESPIRATORY.com…
![Artwork](/static/images/128pixel.png)
1 Targets in early NSCLC: A focus on EGFR-mutant treatment options 16:22
16:22
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי16:22![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchONCOLOGY Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative treatment strategies and best practices for patients with resectable and unresectable early-stage EGFR-mutant NSCLC. She also discusses how the evolving treatment landscape impacts biomarker testing and the importance of multidisciplinary care for optimizing outcomes in these patients. The expert Dr Jennifer Carlisle, Winship Cancer Institute of Emory University, Atlanta, GA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchoncology.org/EGFR-mutant-treatment-options-early-NSCLC…
![Artwork](/static/images/128pixel.png)
1 Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024 57:31
57:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי57:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchONCOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mateos, Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below Clinical themes Approved indications for BCMA-targeting agents, New approaches to the use of existing BCMA-targeting agents, Emerging BCMA-targeting agents The internationally renowned multiple myeloma expert faculty Prof. María-Victoria Mateos: Salamanca, Spain, Dr Rakesh Popat: London, UK, Prof. Evangelos Terpos: Athens, Greece This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024…
![Artwork](/static/images/128pixel.png)
1 Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024 57:31
57:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי57:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchHAEMATOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mateos, Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below Clinical themes Approved indications for BCMA-targeting agents, New approaches to the use of existing BCMA-targeting agents, Emerging BCMA-targeting agents The internationally renowned multiple myeloma expert faculty Prof. María-Victoria Mateos: Salamanca, Spain, Dr Rakesh Popat: London, UK, Prof. Evangelos Terpos: Athens, Greece This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/bcma-mm-comy-eha-2024…
![Artwork](/static/images/128pixel.png)
1 Innovations in glaucoma care: Targeting pathophysiology to expand treatment options 33:45
33:45
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי33:45![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice. The experts Angelo P Tanna, MD - Northwestern University Feinberg School of Medicine, Chicago, IL, USA Courtney E Bovee, MD - Bovee Eye, Tampa Bay, FL, USA Joseph F Panarelli, MD - NYU Langone Eye Center, New York, NY, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Alcon Vision, LLC and is jointly provided by USF Health and touchIME. For further information visit our website: https://touchOPHTHALMOLOGY.com/…
![Artwork](/static/images/128pixel.png)
1 Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents 40:07
40:07
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:07![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchIMMUNOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME. For further information visit our website: touchimmunology.com…
![Artwork](/static/images/128pixel.png)
1 Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents 40:07
40:07
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:07![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchDERMATOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME. For further information visit our website: touchderma.com…
![Artwork](/static/images/128pixel.png)
1 Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors 18:41
18:41
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי18:41![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma. The expert Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/touchfocus_evolving-role-of-icis-in-rm-npc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchIMMUNOLOGY 12:49
12:49
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי12:49![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchIMMUNOLOGY 14:47
14:47
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:47![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchIMMUNOLOGY 15:05
15:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The multidisciplinary team and patient advocate: Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchimmunologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchDERMATOLOGY 15:04
15:04
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:04![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchDERMATOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The multidisciplinary team and patient advocate: Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchDERMATOLOGY 14:46
14:46
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:46![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchDERMATOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY 12:49
12:49
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי12:49![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchDERMATOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY 12:49
12:49
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי12:49![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY 14:47
14:47
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:47![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY 15:05
15:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי15:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The multidisciplinary team and patient advocate: Dermatologist – Prof. Sonja Ständer University of Münster, Münster, Germany Nurse – Ms Michelle Clayton St James’ University Hospital, Leeds, UK Hepatologist – Prof. Gideon Hirschfield University of Toronto, Toronto, Canada Patient Advocate – Mrs Collette Thain MBE PBC Foundation, Edinburgh, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyIME.org/mdt-cholestatic-pruritus-in-patients-with-pbc/…
![Artwork](/static/images/128pixel.png)
1 Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease - touchRESPIRATORY 1:43:40
1:43:40
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי1:43:40![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCLINICAL PERSPECTIVES for touchRESPIRATORY Join Dr Helena Yu, course director, as she discusses the unmet needs and research opportunities in metastatic EGFR -mutant and wildtype NSCLC. By exploring key clinical trial data alongside real-world patient cases, healthcare providers will gain valuable insights into how to effectively implement these findings in clinical practice. In addition, the clinical experts highlight the critical role of biomarker testing in NSCLC for personalizing treatment plans and discuss the importance of patient support in navigating the NSCLC treatment journey. Course director Dr Helena Yu, Memorial Sloan Kettering Cancer Center New York, NY, USA The clinical experts Dr Aaron Lisberg, University of California Los Angeles (UCLA), Los Angeles, CA, USA Dr Antonio Passaro, European Institute of Oncology, Milan, Italy Dr Sara Pilotto, University of Verona, Verona, Italy Ms Jackie Fenemore, Christie NHS Foundation Trust, Manchester, UK Prof. Egbert Smit, Leiden University Medical Center, Leiden, The Netherlands and Netherlands Cancer Institute, Amsterdam, The Netherlands Modules Module 1: EGFR-mutant NSCLC: Navigating the horizon in EGFR-mutant NSCLC (timestamp: 0:00 - 32:33) Module 2: EGFR-wildtype NSCLC: Advances in the treatment landscape (timestamp: 32:34 - 01:06:10) Module 3: Bringing it together (timestamp: 01:06:10 - 01:43:40) This touchPODCAST is for HCPs only. This activity is funded by an educational grant from AstraZeneca Ltd. This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/egfr-and-wildtype-late-stage-nsclc-management/ For further information visit our website: https://touchrespiratoryime.org/egfr-and-wildtype-late-stage-nsclc-management…
![Artwork](/static/images/128pixel.png)
1 Perspectives on EGFR-mutant and wildtype NSCLC Tailoring treatment advances in late-stage disease - touchONCOLOGY 1:43:40
1:43:40
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי1:43:40![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCLINICAL PERSPECTIVES for touchONCOLOGY Join Dr Helena Yu, course director, as she discusses the unmet needs and research opportunities in metastatic EGFR -mutant and wildtype NSCLC. By exploring key clinical trial data alongside real-world patient cases, healthcare providers will gain valuable insights into how to effectively implement these findings in clinical practice. In addition, the clinical experts highlight the critical role of biomarker testing in NSCLC for personalizing treatment plans and discuss the importance of patient support in navigating the NSCLC treatment journey. Course director Dr Helena Yu, Memorial Sloan Kettering Cancer Center New York, NY, USA The clinical experts Dr Aaron Lisberg, University of California Los Angeles (UCLA), Los Angeles, CA, USA Dr Antonio Passaro, European Institute of Oncology, Milan, Italy Dr Sara Pilotto, University of Verona, Verona, Italy Ms Jackie Fenemore, Christie NHS Foundation Trust, Manchester, UK Prof. Egbert Smit, Leiden University Medical Center, Leiden, The Netherlands and Netherlands Cancer Institute, Amsterdam, The Netherlands Modules Module 1: EGFR-mutant NSCLC: Navigating the horizon in EGFR-mutant NSCLC (timestamp: 0:00 - 32:33) Module 2: EGFR-wildtype NSCLC: Advances in the treatment landscape (timestamp: 32:34 - 01:06:10) Module 3: Bringing it together (timestamp: 01:06:10 - 01:43:40) This touchPODCAST is for HCPs only. This activity is funded by an educational grant from AstraZeneca Ltd. This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/egfr-and-wildtype-late-stage-nsclc-management/…
![Artwork](/static/images/128pixel.png)
1 Expanding HER2 horizons: Implications for NSCLC and beyond 41:45
41:45
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי41:45![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchRESPIRATORY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC. The experts Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/her2_in_solid_tumours_and_nsclc/…
![Artwork](/static/images/128pixel.png)
1 Expanding HER2 horizons: Implications for NSCLC and beyond 41:45
41:45
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי41:45![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC. The experts Dr Razelle Kurzrock - Medical Oncologist, Medical College of Wisconsin, Milwaukee, WI, USA Dr Lyudmila Bazhenova - Medical Oncologist, UC San Diego Moores Cancer Center, San Diego, CA, USA Dr Ignacio Wistuba - Pathologist, MD Anderson Cancer Center, Houston, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/her2_in_solid_tumours_and_nsclc/…
![Artwork](/static/images/128pixel.png)
1 Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP? 53:33
53:33
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי53:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchONCOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice. Overview Data reviews with Dr McDonald Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below Clinical themes How does ITP impact the patient and their quality of life? What are the latest data that inform the use of current treatments for chronic ITP? What data are there for emerging chronic ITP treatments and what do they tell us? The internationally renowned ITP expert faculty Dr Vickie McDonald: London, UK Prof. James Bussel: New York, NY, USA, Prof. Waleed Ghanima: Oslo, Norway This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/itp-eha-isth-2024/…
![Artwork](/static/images/128pixel.png)
1 Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP? 53:33
53:33
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי53:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchCONGRESS for touchHAEMATOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP experts, Prof. James Bussel and Prof. Waleed Ghanima, to discuss how these data may apply in clinical practice. Overview Data reviews with Dr McDonald Expert panel discussions with Dr McDonald, Prof. Bussel and Prof. Ghanima on the themes below Clinical themes How does ITP impact the patient and their quality of life? What are the latest data that inform the use of current treatments for chronic ITP? What data are there for emerging chronic ITP treatments and what do they tell us? The internationally renowned ITP expert faculty Dr Vickie McDonald: London, UK Prof. James Bussel: New York, NY, USA, Prof. Waleed Ghanima: Oslo, Norway This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Sanofi and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/itp-eha-isth-2024/…
![Artwork](/static/images/128pixel.png)
1 Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes 41:33
41:33
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי41:33![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM. The experts Prof. Stewart Harris, Western University, London, Ontario, Canada, Dr Anders Carlson, International Diabetes Center at Park Nicollet, Minneapolis, MN, USA, Prof. Shannon Idzik, University of Maryland School of Nursing, Baltimore, MD, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchENDOCRINOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 Personalizing care within the MDT for patients with early through to advanced RCC 19:36
19:36
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי19:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communication strategies and shared decision-making when managing diverse and/or underserved populations with RCC. The expert Prof. Hans Hammers, UT Southwestern, Dallas, TX, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/…
![Artwork](/static/images/128pixel.png)
1 Selecting ART: Working with people living with HIV to find the best regimen 39:45
39:45
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי39:45![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The experts Dr Christoph Boesecke – University of Bonn, Bonn, Germany Dr Tristan Barber – Royal Free London NHS Foundation Trust, London, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical educational grant from ViiV Healthcare. This activity is provided by touchIME. For further information visit our website: https://touchinfectiousdiseases.com/education/hiv-art-selection-shared-decision-making/…
![Artwork](/static/images/128pixel.png)
1 Thyroid eye disease: An evolving continuum of care 38:00
38:00
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי38:00![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA Dr Mario Salvi, University of Milan, Milan, Italy Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit: https://touchophthalmologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/…
![Artwork](/static/images/128pixel.png)
1 Thyroid eye disease: An evolving continuum of care 38:00
38:00
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי38:00![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA Dr Mario Salvi, University of Milan, Milan, Italy Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit: https://touchendocrinologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/…
![Artwork](/static/images/128pixel.png)
1 Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies 47:09
47:09
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי47:09![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchTALKS for touchNEUROLOGY A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. The expert Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchneurology.com…
![Artwork](/static/images/128pixel.png)
1 Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies 47:09
47:09
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי47:09![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchTALKS for touchCARDIO A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. The expert Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchCARDIO.com…
![Artwork](/static/images/128pixel.png)
1 Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches 16:01
16:01
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי16:01![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchFOCUS for touchONCOLOGY Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…
![Artwork](/static/images/128pixel.png)
1 The path from detection to personalized long-term care for Fabry disease 36:05
36:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי36:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchENDOCRINOLOGY.com…
![Artwork](/static/images/128pixel.png)
1 The path from detection to personalized long-term care for Fabry disease 36:05
36:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי36:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchCARDIO Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchCARDIO.com…
![Artwork](/static/images/128pixel.png)
1 The path from detection to personalized long-term care for Fabry disease 36:05
36:05
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי36:05![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchNEUROLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchNEUROLOGY.com…
![Artwork](/static/images/128pixel.png)
1 Demystifying virology: The link between the HIV life cycle and ART 37:54
37:54
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי37:54![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV. The experts Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium Prof. José Arribas - La Paz Hospital, Madrid, Spain Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME. For further information visit our website: https://touchinfectiousdiseases.com/education/demystifying-virology-the-link-between-the-hiv-life-cycle-and-art/…
![Artwork](/static/images/128pixel.png)
1 Knowledge for nurses ADC updates in breast cancer 40:21
40:21
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:21![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchONCOLOGY Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the treatment of patients with breast cancer. This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer…
![Artwork](/static/images/128pixel.png)
1 Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma 39:16
39:16
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי39:16![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. The experts Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA, Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA, Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA. This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME. For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma…
![Artwork](/static/images/128pixel.png)
1 Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma 39:16
39:16
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי39:16![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. The experts Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA, Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA, Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA. This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME. For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma…
![Artwork](/static/images/128pixel.png)
1 Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies 37:31
37:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי37:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchRESPIRATORY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. The experts Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/…
![Artwork](/static/images/128pixel.png)
1 Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies 37:31
37:31
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי37:31![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchONCOLOGY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. The experts Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/…
![Artwork](/static/images/128pixel.png)
1 Early diagnosis and treatment of NMOSD: Practical insights 40:30
40:30
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:30![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment. The experts: Prof. John Chen - Mayo Clinic, Rochester, MN, USA Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment https://touchneurologyime.org/nmosd_diagnosis_treatment…
![Artwork](/static/images/128pixel.png)
1 Early diagnosis and treatment of NMOSD: Practical insights 40:30
40:30
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי40:30![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchOPTHAMOLOGY Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment. The experts: Prof. John Chen - Mayo Clinic, Rochester, MN, USA Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Germany This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment https://touchneurologyime.org/nmosd_diagnosis_treatment…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY 14:00
14:00
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:00![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY 11:34
11:34
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי11:34![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pathologist: Dr Eric Gars, Gainesville, FL, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY 13:32
13:32
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:32![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Critical care pharmacist: Prof. Rob MacLaren, Denver, CO This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchHAEMATOLOGY 12:01
12:01
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי12:01![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchHAEMATOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting Best practice for the multidisciplinary team - Part 1 touchIMMUNOLOGY 14:00
14:00
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:00![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchIMMUNOLOGY 11:34
11:34
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי11:34![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Pathologist: Dr Eric Gars, Gainesville, FL, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchIMMUNOLOGY 13:32
13:32
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:32![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA Critical care pharmacist: Prof. Rob MacLaren, Denver, CO This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 4 touchIMMUNOLOGY 12:01
12:01
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי12:01![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchIMMUNOLOGY Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line. The multidisciplinary team HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA This touchPODCAST is for healthcare professionals in the USA only. This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.…
![Artwork](/static/images/128pixel.png)
1 Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis 43:29
43:29
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי43:29![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis. This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA). For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/…
![Artwork](/static/images/128pixel.png)
1 Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:48
51:48
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי51:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. For further information visit: https://touchoncologyime.org/mdt-insights-systemic-mastocytosis…
![Artwork](/static/images/128pixel.png)
1 Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:48
51:48
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי51:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. For further information visit: https://touchhaematologyime.org/mdt-insights-systemic-mastocytosis…
![Artwork](/static/images/128pixel.png)
1 Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:48
51:48
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי51:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchDERMATOLOGY Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. For further information visit: https://touchdermaime.org/mdt-insights-systemic-mastocytosis…
![Artwork](/static/images/128pixel.png)
1 Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management 51:48
51:48
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי51:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care. The experts Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium Dr Sigurd Broesby-Olsen, Odense University Hospital, Odense, Denmark Prof. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. For further information visit: https://touchimmunologyime.org/mdt-insights-systemic-mastocytosis…
![Artwork](/static/images/128pixel.png)
1 Immunotherapy for early-stage, resectable NSCLC 34:52
34:52
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:52![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice. The expert Prof. Heather A Wakelee – Stanford University, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchrespiratoryime.org/io-early-stage-nsclc/…
![Artwork](/static/images/128pixel.png)
1 Immunotherapy for early-stage, resectable NSCLC 34:52
34:52
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי34:52![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice. The expert Prof. Heather A Wakelee – Stanford University, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/io-early-stage-nsclc/…
![Artwork](/static/images/128pixel.png)
1 Impact of pharmacotherapies for achondroplasia – Discussion 4 / 4 19:20
19:20
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי19:20![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia The multidisciplinary team and patient advocate: MFM specialist - Prof. Karin Blakemore Johns Hopkins University School of Medicine, Baltimore, MD, USA Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany Paediatrician - Prof. Janet Legare University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Patient advocate - Ms Carly Kutner Freehold, NJ, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/…
![Artwork](/static/images/128pixel.png)
1 Monitoring and early treatment initiation - Discussion 3 13:48
13:48
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי13:48![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany Patient advocate - Ms Carly Kutner Freehold, NJ, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/…
![Artwork](/static/images/128pixel.png)
1 Early recognition of achondroplasia – Discussion 2 / 4 16:24
16:24
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי16:24![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications. The multidisciplinary team and patient advocate: Paediatrician - Prof. Janet Legare University of Wisconsin School of Medicine and Public Health, Madison, WI, USA MFM specialist - Prof. Karin Blakemore Johns Hopkins University School of Medicine, Baltimore, MD, USA Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany Patient advocate - Ms Carly Kutner Freehold, NJ, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/…
![Artwork](/static/images/128pixel.png)
1 MDT management of achondroplasia – Discussion 1 / 4 14:14
14:14
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי14:14![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchMDT for touchENDOCRINOLOGY Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals The multidisciplinary team: Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany MFM specialist - Prof. Karin Blakemore Johns Hopkins University School of Medicine, Baltimore, MD, USA Paediatrician - Prof. Janet Legare University of Wisconsin School of Medicine and Public Health, Madison, WI, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/…
![Artwork](/static/images/128pixel.png)
1 Advanced urothelial carcinoma: Expert guidance to navigate an evolving therapeutic landscape 32:08
32:08
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי32:08![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchONCOLOGY In this activity, Prof. Thomas Powles, an oncologist specializing in bladder cancer, provides an update on the latest developments in the treatment of advanced urothelial carcinoma, including the latest guideline recommendations, supporting clinical data and factors to support decision making in clinical practice. The expert Prof. Thomas Powles, Barts Cancer Centre, London, UK This touchPODCAST is for HCPs outside of the UK and USA only. This activity is jointly funded by an independent medical education grant from Astellas Pharma Inc. and Seagen Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/advanced-urothelial-carcinoma-expert-guidance-to-navigate-an-evolving-therapeutic-landscape…
![Artwork](/static/images/128pixel.png)
1 Clinical decision making with immunotherapies in advanced or recurrent endometrial cancer 39:11
39:11
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי39:11![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
touchEXPERT OPINIONS for touchONCOLOGY A gynaecological oncologist considers the expanding role of molecular classification in endometrial cancer and provides an update on the use of immune checkpoint inhibitors to treat patients with advanced or recurrent disease, including key guideline recommendations, supporting data and considerations for clinical practice. The expert Prof. David Cibula, General University Hospital and Charles University, Prague, Czech Republic This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck & Co, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/immunotherapy-in-endometrial-cancer/…
ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.